Women are missing crucial cancer knowledge
Today we've released new research on how much women know about breast cancer and ovarian cancer symptoms.
Read our latest updates from research breakthroughs to government actions to fundraising heroes.
Today we've released new research on how much women know about breast cancer and ovarian cancer symptoms.
New ovarian cancer drug rucaparib (Rubraca®) is now available on the NHS.
We look at what we're doing to transform GP knowledge of ovarian cancer to improve early diagnosis.
News from the European Society of Medical Oncology (ESMO) conference means more women could be able to access innovative treatments earlier.
Today we’re launching the ovarian cancer care standard. The standard sets out five principles that, when followed by healthcare professionals, will support women to live well with ovarian cancer from the moment they are diagnosed.
Transformational funding from the Peter Sowerby Foundation will help us tackle the problem in a radically new way.
One in five women in the UK (22 per cent) mistakenly believes that a smear test (cervical screening) can detect ovarian cancer, according to research we carried out with YouGov.
Sign up to receive emails and keep up to date on all things Target Ovarian Cancer
Sign up